Review article · 2025 · Open access

AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential

Chunyu Ma, Han Zhang, Yiwei Rao, Xinyu Jiang, Boheng Liu, Zhikang Sun, Zhenyu Song, Yuan Gao, Yuhao Cui, Xinyu Liu, Zedong Li

npj Digital Medicine, 9(1), 25 · Published 11 December 2025 · DOI 10.1038/s41746-025-02198-6

Open PDFView at the publisherCite this paper

In brief

“AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential” is a 2025 review article by Chunyu Ma and 10 co-authors, published in npj Digital Medicine. OpenAlex counts 71 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at npj Digital Medicine.

Citations
71
Most cited in
2026 (71)
Field-weighted impact
3.18
References
315
Authors
11

Abstract

AI-driven virtual cell models show the potential to transform the paradigm of life sciences research by integrating multimodal omics data (e.g., single-cell transcriptomics and proteomics) with advanced algorithms such as deep generative models and graph neural networks to enable high-precision predictions of drug responses, gene perturbations, and disease progression. These models enable high-precision predictions of drug responses, gene perturbations, and disease progression. This review outlines the technical pathways and validation mechanisms of virtual cells, emphasizing a closed-loop workflow from computational evaluation to experimental verification using CRISPR assays and organoid platforms. The applications of virtual cells in personalized drug screening and disease modeling are highlighted, showcasing their potential to reduce animal testing and optimize therapy. However, challenges in regulatory acceptance, data privacy, and model interpretability remain. Global policy and standardization trends are driving clinical translation, and future advancements will involve cross-disciplinary integration and greater standardization to enhance the impact of virtual cells in precision medicine and drug discovery.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ma, C., Zhang, H., Rao, Y., Jiang, X., Liu, B., Sun, Z., Song, Z., Gao, Y., Cui, Y., Liu, X., & Li, Z. (2025). AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential. npj Digital Medicine, 9(1), 25. https://doi.org/10.1038/s41746-025-02198-6

MLA 9

Ma, Chunyu, et al. “AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential.” npj Digital Medicine, vol. 9, no. 1, 2025, p. 25. https://doi.org/10.1038/s41746-025-02198-6.

Chicago

Ma, Chunyu, Han Zhang, Yiwei Rao, Xinyu Jiang, Boheng Liu, Zhikang Sun, Zhenyu Song, et al. 2025. “AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential.” npj Digital Medicine 9 (1): 25. https://doi.org/10.1038/s41746-025-02198-6.

Harvard

Ma, C. et al. (2025) ‘AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential’, npj Digital Medicine, 9(1), p. 25. doi:10.1038/s41746-025-02198-6.

IEEE

C. Ma et al., “AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential,” npj Digital Medicine, vol. 9, no. 1, p. 25, 2025, doi: 10.1038/s41746-025-02198-6.

BibTeX

@article{ma2025driven,
  title     = {{AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential}},
  author    = {Ma, Chunyu and Zhang, Han and Rao, Yiwei and Jiang, Xinyu and Liu, Boheng and Sun, Zhikang and Song, Zhenyu and Gao, Yuan and Cui, Yuhao and Liu, Xinyu and Li, Zedong},
  journal   = {npj Digital Medicine},
  year      = {2025},
  volume    = {9},
  number    = {1},
  pages     = {25},
  doi       = {10.1038/s41746-025-02198-6},
  url       = {https://doi.org/10.1038/s41746-025-02198-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • virtual cell model
  • artificial intelligence
  • deep generative models
  • graph neural networks
  • single-cell transcriptomics
  • single-cell proteomics
  • drug response prediction
  • disease progression prediction

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Ma, C., Zhang, H., Rao, Y., Jiang, X., Liu, B., Sun, Z., Song, Z., Gao, Y., Cui, Y., Liu, X., & Li, Z. (2025). AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential. npj Digital Medicine, 9(1), 25. https://doi.org/10.1038/s41746-025-02198-6

How many times has this paper been cited?

71 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at npj Digital Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Chunyu Ma, Han Zhang, Yiwei Rao, Xinyu Jiang, Boheng Liu, Zhikang Sun, Zhenyu Song, Yuan Gao, Yuhao Cui, Xinyu Liu, Zedong Li.

What is the DOI of this paper?

10.1038/s41746-025-02198-6, permanently at https://doi.org/10.1038/s41746-025-02198-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.